Spatial proteome

Show results for

Proteomics (432)
Unknown (356)
Transcriptomics (67)
Genomics (46)
Models (33)
Other (15)
Metabolomics (3)

Organisms

Homo sapiens (89)
Mus musculus (36)
Saccharomyces cerevisiae (4)
Daphnia pulex (3)
Arabidopsis thaliana (3)
Escherichia coli (3)
Rattus norvegicus (3)
Macaca mulatta (2)
Scutellaria baicalensis (2)
Thermotoga maritima MSB8 (1)
Rhizobium etli CFN 42 (1)
Pectobacterium carotovorum (1)
Salmonella enterica (1)
Chlamydomonas reinhardtii (1)
Medicago truncatula (1)
Zea mays (1)
Salmo salar (1)
Pseudomonas putida KT2440 (1)
Escherichia coli K-12 (1)
Pseudomonas aeruginosa (1)
Drosophila melanogaster (1)
Human coronavirus OC43 (1)
Triticum aestivum (1)
Caenorhabditis elegans (1)
Bos taurus (1)
Lactuca sativa (1)
Mus (1)
Nannochloropsis oceanica (1)
Nicotiana benthamiana (1)
Oryza sativa (1)

Organisms

Homo sapiens (19)
Mus musculus (11)
Rattus norvegicus (2)
Saccharomyces cerevisiae (2)
Alviniconcha (1)
Triticum aestivum (1)

Repository

pride (347)
biostudies-arrayexpress (46)
ENA (44)
MassIVE (41)
geo (36)
BioModels (33)
iProX (26)
jPOST (10)
GPMDB (5)
MetaboLights (3)
PanoramaPublic (2)
EGA (1)
PAXDB (1)
PeptideAtlas (1)

Tissue

Cell culture (75)
Brain (62)
Epithelial cell (31)
Liver (20)
Permanent cell line cell (17)
Heart (10)
Lung (10)
Fibroblast (9)
Hepatocyte (9)
Colon (8)
Kidney (8)
B cell (7)
T cell (7)
Embryo (6)
Skin (6)
Malignant cell (5)
Neuron (5)
Plant cell (5)
Tonsil (5)
Cell suspension culture (4)
Early embryonic cell (4)
Sperm (4)
Stem cell (4)
Whole body (4)
Blood cell (3)
Blood plasma (3)
Breast (3)
Diploid cell (3)
Embryonic stem cell (3)
Others (1)

Disease

Colon cancer (8)
Breast cancer (7)
Disease free (7)
Brain glioblastoma multiforme (6)
Mixed disorder as reaction to stress (6)
Not Available (5)
Alzheimer's disease (4)
Glioblastoma (4)
Myocardial ischemia (4)
Influenza (3)
Acute leukemia (2)
Bone osteosarcoma (2)
Lung adenocarcinoma (2)
Lymphoma (2)
Myocardial infarction (2)
Pancreatic ductal adenocarcinoma (2)
Prostate adenocarcinoma (2)
Acquired immunodeficiency syndrome (1)
Alport syndrome (1)
Axonal neuropathy (1)
Carcinoma (1)
Down syndrome (1)
Duchenne muscular dystrophy (1)
Hepatocellular carcinoma (1)
Huntington Disease (1)
Moyamoya disease (1)
Parkinson's disease (1)
Plasmodium falciparum malaria (1)
Sjogren's Syndrome (1)
Trypanosomiasis (1)

Technology Type

Mass Spectrometry (347)
Shotgun proteomics (164)
Bottom-up proteomics (91)
Data-dependent acquisition (42)
Affinity purification coupled with mass spectrometry proteomics (36)
Data-independent acquisition (27)
SWATH MS (17)
Gel-based experiment (15)
Top-down proteomics (15)
Chemical cross-linking coupled with mass spectrometry proteomics (9)
DiaPASEF (4)
Mass spectrometry imaging (4)
Mass spectrometry (2)
MSE (2)
NMR spectroscopy (1)
Affinity proteomics (1)
HDMSE (1)
Immunopeptidomics (1)
Metaproteomics (1)
Proteogenomics (1)
RNA mass spectrometry (1)
SRM/MRM (1)

Instrument Platform

Q Exactive (7)
Instrument (5)
Orbitrap Eclipse (5)
Q Exactive Plus (5)
Orbitrap Fusion Lumos (4)
Q Exactive HF (4)
Q Exactive HF-X (4)
LTQ Orbitrap (3)
LTQ Orbitrap Velos (3)
LTQ Orbitrap XL (3)
Orbitrap Fusion (3)
Illumina NovaSeq 6000 (2)
Orbitrap Astral (2)
Orbitrap Exploris 480 (2)
MacBook Pro 64Gb RAM; 16-core (1)
Qubit 2.0 Fluorometer; Agilent TapeStation 4200 (1)
10X Genomics Chromium (1)
Infors HT Multitron shaker (1)
Not applicable (1)
Scanning hardware (1)
Illumina MiSeq (1)
Illumina HiSeq 4000 (1)
6550 iFunnel Q-TOF LC/MS (Agilent instrument model) (1)
AmaZon ETD (1)
Impact (1)
LTQ (1)
LTQ Orbitrap Elite (1)
LTQ Velos (1)
MaXis (1)
Q Exactive HF-X (Thermo Scientific instrument model) (1)

Publication Date

2025 (80)
2024 (73)
2023 (61)
2022 (57)
2015 (45)
2026 (45)
2021 (44)
2019 (23)
2018 (17)
2020 (17)
2017 (13)
2016 (12)
2011 (11)
2010 (11)
2014 (6)
2013 (6)
2012 (5)
2009 (2)
2008 (2)
2007 (1)
2003 (1)

UNIPROT ID/AC

2A5D_YEAST (1)
2AAA_YEAST (1)
2ABA_YEAST (1)
2NDP_YEAST (1)
3HAO_YEAST (1)
4932.YBR084C-A (1)
4932.YDL184C (1)
4932.YEL054C (1)
4932.YER102W (1)
4932.YHR055C (1)
4932.YIL018W (1)
4932.YIL069C (1)
4932.YJR145C (1)
4932.YKR059W (1)
4932.YKR094C (1)
4932.YLR035C-A (1)
4932.YML026C (1)
4932.YML132W (1)
4932.YMR143W (1)
4932.YNL030W (1)
4932.YNL031C (1)
4932.YNL162W (1)
4932.YOR133W (1)
4932.YOR182C (1)
4932.YPL090C (1)
4932.YPL220W (1)
4932.YPR043W (1)
4932.YPR080W (1)
4932.YPR132W (1)
6P21_YEAST (1)

ENSEMBL ID

ENSG00000170477 (1)
ENSG00000247315 (1)

CHEBI ID

CHEBI:3110 (32)
CHEBI:16874 (32)
CHEBI:16565 (32)
CHEBI:27515 (32)
CHEBI:36528 (32)
CHEBI:15958 (32)
CHEBI:17927 (32)
CHEBI:28101 (32)
CHEBI:28865 (32)
CHEBI:17687 (32)
CHEBI:36274 (32)
CHEBI:16675 (32)
CHEBI:28058 (32)
CHEBI:17292 (32)
CHEBI:16091 (32)
CHEBI:28648 (32)
CHEBI:28175 (32)
CHEBI:18163 (32)
CHEBI:17798 (32)
CHEBI:17364 (32)
CHEBI:17474 (32)
CHEBI:27870 (32)
CHEBI:27910 (32)
CHEBI:17500 (32)
CHEBI:17737 (32)
CHEBI:15700 (32)
CHEBI:17123 (32)
CHEBI:17864 (32)
CHEBI:16797 (32)
CHEBI:16427 (32)

Metabolite Name

Taurine (3)
Ribose (2)
Lysine (2)
Glutamine (2)
Valine (2)
Uracil (2)
Glycine (2)
Alpha-Ecdysone 2 (1)
5-alpha-Cholestan-3-one 1 (1)
4-Cholesten-3-one 4 (1)
Cortexolone 3 (1)
Tetrahydrocorticosterone 3 (1)
4-Androsten-19-ol-3,17-dione 2 (1)
Isomaltose 2 (1)
5'-methylthioadenosine 1 (1)
Gentiobiose 1 (1)
Prostaglandin E2 1 (1)
Sophorose 2 (1)
Lactobionic Acid 1 (1)
Dihydrotestosterone (1)
Androsterone 1 (1)
Docosanoic acid methyl ester (1)
Piceatannol 2 (1)
D-erythro-sphingosine 1 (1)
Uridine 2 (1)
5-Methoxytryptamine 2 (1)
Pyridoxal phosphate 2 (1)
Glucose-6-phosphate 2 (1)
Glucoheptonic acid 1 (1)
Tryptophan 1 (1)

First Public Date

2026 (11)
2025 (9)
2024 (9)
2022 (4)
2021 (3)
2023 (2)
2015 (2)
2020 (1)
2018 (1)
2017 (1)
2014 (1)

Modelling Approach

Partial differential equation model (1)

Lab affiliation

Functional Proteomics, ICR (4)
Department of Pharmaceutical Sciences, University of Illinois College of Pharmacy,Chicago,IL,USA Richard and Loan Hill Department of Biomedical Engineering, University of Illinois College of Engineering,Chicago, IL,USA University of Illinois Cancer Center,Chicago, IL,USA (3)
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (3)
Professor Institutt for kreftforskning og molekylær medisin Erling Skjalgssons g 1, Laboratoriesenteret * 231.05.036 Trondheim 7030, Norway (3)
Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany (3)
1) Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Switzerland 2) Faculty of Science, University of Zurich, Zurich, Switzerland (2)
Chemistry Department, Wayne State University, US (2)
Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, 28220 Madrid, Spain (2)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States (2)
Department of Biochemistry, University of Cambridge (2)
Department of Biochemistry, University of Cambridge, UK (2)
Department of Biology University of California, Riverside (2)
Department of Cell Biology, Harvard Medical School, Boston MA 02115 (2)
Department of Oncology-Pathology, Karolinska Institute and Scilifelab, Solna, Sweden (2)
Department of Proteomics and Signal Transduction Max Planck Institute of Biochemistry Germany (2)
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany (2)
Department of Proteomics and Signal Transduction, Systems Biology of Membrane Trafficking Research Group, Max-Planck Institute of Biochemistry, Martinsried, Germany (2)
Department of Structural Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) (2)
Director of Women’s Health Research Women’s Service Line Inova Health System (2)
Emmy-Noether Research Group Cellular Proteomics and Metabolic Signaling Institute for Diabetes and Obesity Helmholtz Diabetes Center Germany (2)
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center (2)
International Centre for Cancer Vaccine Science, University of Gdansk, Kladki 24, Gdansk, Poland (2)
King's College London - Cardiovascular Division (2)
Maastricht MultiModal Molecular Imaging (M4I) Institute, Division of Imaging Mass Spectrometry, Maastricht University, Maastricht, The Netherlands (2)
Ottawa Institute of Systems Biology and Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (2)
Principle Investigator (2)
Shanghai Institute of Materia Medica (2)
Univ. Bordeaux, Bordeaux Proteome, Bordeaux, France (2)
Univ. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, F-59000 Lille, France (2)
University of Copenhagen, Section of Microbiology (2)

IsPrivate

False (33)

Model Flag

Non Kinetic (32)

Modification

4x(15)N labeled L-arginine (3)
2x(15)N labeled L-lysine (2)
15.994915 (1)
4-tetrahydrothiazine-3-carboxylic acid (1)
57.021464 (1)
Not available (1)

Study type

Transcription profiling by array (25)
RNA-seq of coding RNA (10)
Proteomic profiling by array (3)
Comparative genomic hybridization by array (2)
Unknown experiment type (1)
RNA-seq of non coding RNA from single cells (1)
Proteomic profiling by mass spectrometer (1)
Transcription profiling by tiling array (1)
RNA-seq of coding RNA from single cells (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2024 (69)
2025 (58)
2022 (40)
2023 (37)
2021 (28)
2010 (20)
2018 (18)
2011 (16)
2015 (15)
2020 (15)
2016 (13)
2014 (13)
2012 (12)
2019 (11)
2013 (9)
2017 (8)
2026 (6)
2008 (5)
2007 (3)
2009 (2)
2006 (1)
2005 (1)
2003 (1)
2000 (1)

Previous page
1 / 96
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 96
Next page

Sort by:

Relevance

Page size

Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients

BACKGROUND: The gut-brain axis and the intestinal microbiota are emerging as key players in health and disease. Shifts in intestinal microbiota composition affect a variety of systems, however, evidence of their direct impact on cognitive functions is still lacking. We tested whe...

2021-12-17 | MTBLS1437 | MetaboLights

Spatial SILAC Regorafenib Treated Bottom-up Proteomic Analysis

Developing effective model systems to evaluate new potential chemotherapeutic reagents is critical. Three-dimensional cell cultures, such as spheroids, aid in bridging the gap between commonly used monolayer cell cultures and significantly more complex and expensive animal models. Spheroid model sys...

ORGANISM(S): Homo sapiens (Human)

2024-08-09 | PXD038958 | Pride

Uhlén2015 - Human tissue-based proteome metabolic network - stomach

Uhlén2015 - Human tissue-based proteome metabolic network - stomach Human stomach specific proteome metabolic network This model is described in the article: Tissue-based map of the human proteome Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, S...

2015-01-28 | MODEL1411240017 | BioModels

Uhlén2015 - Human tissue-based proteome metabolic network - adipose

Uhlén2015 - Human tissue-based proteome metabolic network - adipose Human adipose tissue specific proteome metabolic network This model is described in the article: Tissue-based map of the human proteome Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinog...

2015-01-28 | MODEL1411240001 | BioModels

Uhlén2015 - Human tissue-based proteome metabolic network - skeletal

Uhlén2015 - Human tissue-based proteome metabolic network - skeletal Human skeletal tissue specific proteome metabolic network This model is described in the article: Tissue-based map of the human proteome Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardin...

2015-01-28 | MODEL1411240009 | BioModels

Uhlén2015 - Human tissue-based proteome metabolic network - testis

Uhlén2015 - Human tissue-based proteome metabolic network - testis Human testis specific proteome metabolic network This model is described in the article: Tissue-based map of the human proteome Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Siv...

2015-01-28 | MODEL1411240018 | BioModels

Uhlén2015 - Human tissue-based proteome metabolic network - adrenal

Uhlén2015 - Human tissue-based proteome metabolic network - adrenal Human adrenal specific proteome metabolic network This model is described in the article: Tissue-based map of the human proteome Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, S...

2015-01-28 | MODEL1411240002 | BioModels

Uhlén2015 - Human tissue-based proteome metabolic network - endometrium

Uhlén2015 - Human tissue-based proteome metabolic network - endometrium Human endometrium specific proteome metabolic network This model is described in the article: Tissue-based map of the human proteome Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardino...

2015-01-28 | MODEL1411240010 | BioModels

Uhlén2015 - Human tissue-based proteome metabolic network - appendix

Uhlén2015 - Human tissue-based proteome metabolic network - apendix Human apendix specific proteome metabolic network This model is described in the article: Tissue-based map of the human proteome Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, S...

2015-01-28 | MODEL1411240004 | BioModels

Uhlén2015 - Human tissue-based proteome metabolic network - kidney

Uhlén2015 - Human tissue-based proteome metabolic network - kidney Human kidney specific proteome metabolic network This model is described in the article: Tissue-based map of the human proteome Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Siv...

2015-01-28 | MODEL1411240019 | BioModels

Previous page
1 / 96
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 96
Next page

Sort by:

Relevance

Page size

952 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Lab affiliation

Tags

IsPrivate

Model Flag

Modification

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets